Patient Guide: NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 43 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT05704829
Status: ACTIVE_NOT_RECRUITING
Condition: HER2-positive Early Breast Cancer
Phase: PHASE2

Find a Study Location Near You

This study is available at 43 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Baden-Baden, Baden-Wurttemberg
  • • Freiburg im Breisgau, Baden-Wurttemberg
  • • Tübingen, Baden-Wurttemberg
  • • And 40 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer - Join Clinical Trial NCTNCT05704829

How to Join This Clinical Trial - NCTNCT05704829

Learn how to participate in this PHASE2 trial studying an investigational therapy for HER2-positive Early Breast Cancer. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with HER2-positive Early Breast Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
HER2-positive Early Breast Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05704829 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 43 locations. Find a study site near you:

Clinical Research Site

Baden-Baden, Baden-Wurttemberg 76532 - Germany

Status: Contact for availability

Clinical Research Site

Freiburg im Breisgau, Baden-Wurttemberg 79110 - Germany

Status: Contact for availability

Clinical Research Site

Tübingen, Baden-Wurttemberg 72076 - Germany

Status: Contact for availability

Clinical Research Site

Ulm, Baden-Wurttemberg 89075 - Germany

Status: Contact for availability

Clinical Research Site

Augsburg, Bavaria 86150 - Germany

Status: Contact for availability

Clinical Research Site

Augsburg, Bavaria 86156 - Germany

Status: Contact for availability

Clinical Research Site

Munich, Bavaria 80336 - Germany

Status: Contact for availability

Clinical Research Site

Munich, Bavaria 80634 - Germany

Status: Contact for availability

Clinical Research Site

Bremerhaven, City state Bremen 27574 - Germany

Status: Contact for availability

Clinical Research Site

Rostock, ecklenburg-Vorpommerns 18059 - Germany

Status: Contact for availability

And 33 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for HER2-positive Early Breast Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation